P
Patricia S. Goode
Researcher at University of Alabama at Birmingham
Publications - 165
Citations - 10179
Patricia S. Goode is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Urinary incontinence & Randomized controlled trial. The author has an hindex of 51, co-authored 164 publications receiving 9150 citations. Previous affiliations of Patricia S. Goode include Emory University & United States Department of Veterans Affairs.
Papers
More filters
Journal ArticleDOI
Prevalence and Trends of Symptomatic Pelvic Floor Disorders in U.S. Women
Jennifer M. Wu,Camille P. Vaughan,Patricia S. Goode,David T. Redden,David T. Redden,David T. Redden,Kathryn L. Burgio,Kathryn L. Burgio,Kathryn L. Burgio,Holly E. Richter,Holly E. Richter,Holly E. Richter,Alayne D. Markland,Alayne D. Markland,Alayne D. Markland +14 more
TL;DR: Although rates of pelvic floor disorders did not change from 2005 to 2010, these conditions remain common, with one fourth of adult U.S. women reporting at least one disorder.
Journal ArticleDOI
Fecal incontinence in US adults: epidemiology and risk factors.
William E. Whitehead,Lori G. Borrud,Patricia S. Goode,Patricia S. Goode,Susan Meikle,Elizabeth R. Mueller,Ashok K. Tuteja,Ashok K. Tuteja,Alison C. Weidner,Milena M. Weinstein,Wen Ye +10 more
TL;DR: Fecal incontinence is a prevalent age-related disorder and Chronic diarrhea is a strong modifiable risk factor that may form the basis for prevention and treatment.
Journal ArticleDOI
Behavioral vs drug treatment for urge urinary incontinence in older women: a randomized controlled trial
Kathryn L. Burgio,Julie L. Locher,Patricia S. Goode,J M Hardin,B J McDowell,M. Dombrowski,D. Candib +6 more
TL;DR: Behavioral treatment is a safe and effective conservative intervention that should be made more readily available to patients as a first-line treatment for urge and mixed incontinence.
Journal ArticleDOI
Safety and benefit of discontinuing statin therapy in the setting of advanced, life-limiting illness a randomized clinical trial
Jean S. Kutner,Patrick J. Blatchford,Donald H. Taylor,Christine S. Ritchie,Christine S. Ritchie,Janet Bull,Diane L. Fairclough,Laura C. Hanson,Thomas W. LeBlanc,Greg Samsa,Steven Wolf,Noreen M. Aziz,David C. Currow,Betty Ferrell,Nina D. Wagner-Johnston,S. Yousuf Zafar,James F. Cleary,Sandesh Dev,Patricia S. Goode,Patricia S. Goode,Arif H. Kamal,Cordt T. Kassner,Elizabeth Kvale,Elizabeth Kvale,Janelle G. McCallum,Adeboye Ogunseitan,Steven Z. Pantilat,Russell K. Portenoy,Maryjo Prince-Paul,Jeff A. Sloan,Keith M. Swetz,Charles F. von Gunten,Amy P. Abernethy +32 more
TL;DR: It is suggested that stopping statin medication therapy is safe and may be associated with benefits including improved QOL, use of fewer nonstatin medications, and a corresponding reduction in medication costs.
Journal ArticleDOI
Pressure ulcer risk factors among hospitalized patients with activity limitation.
TL;DR: The results suggest that nonblanchable erythema, lymphopenia, immobility, dry skin, and decreased body weight are independent and significant risk factors for pressure ulcers in hospitalized patients whose activity is limited to bed or chair.